Privia Health Group (PRVA)
(Delayed Data from NSDQ)
$16.95 USD
-0.21 (-1.22%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $16.96 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PRVA 16.95 -0.21(-1.22%)
Will PRVA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for PRVA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PRVA
DH or PRVA: Which Is the Better Value Stock Right Now?
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q1 Earnings
PRVA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Privia Health (PRVA) Misses Q1 Earnings and Revenue Estimates
Privia Health (PRVA) Reports Q4 Earnings: What Key Metrics Have to Say
Privia Health (PRVA) Misses Q4 Earnings Estimates
Other News for PRVA
Vanquis Banking Group Shares Capital Update
Privia Receives HFMA’s MAP Award for High Performance in Revenue Cycle for Performance Year 2023
Vanquis Banking Group Appoints New Advisors
Norges Bank Increases Stake in Vanquis Banking Group
Schroders Plc Ups Stake in Vanquis Banking Group